Shanghai, China

Yun Jin

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014-2022

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):

Title: The Innovative Contributions of Yun Jin

Introduction

Yun Jin is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, he has made remarkable advancements in the development of compounds that target critical neurological pathways.

Latest Patents

Among his latest patents is the invention of substituted [1,2,4]triazolo[3,4-a]phthalazines as modulators of GABA receptor activity. This invention discloses phthalazine isoxazole alkoxy derivatives, along with their preparation methods, pharmaceutical compositions, and uses. The compound represented by Formula I exhibits an excellent inverse agonist effect with respect to α5-GABA. Another notable patent involves substituted fused pyrazole compounds that serve as LRRK2 inhibitors. These compounds, including substituted indazoles, inhibit LRRK2 kinase activity and are intended for use in the treatment of Parkinson's disease.

Career Highlights

Yun Jin has worked with reputable companies such as Glaxo Group Limited and SAP SE, where he has honed his skills and contributed to groundbreaking research. His work has been instrumental in advancing therapeutic options for various neurological conditions.

Collaborations

Yun Jin has collaborated with esteemed colleagues, including Zehong Wan and Wen-Syan Li, to further enhance the impact of his research and innovations.

Conclusion

Yun Jin's innovative work in the pharmaceutical field, particularly in developing compounds for neurological disorders, showcases his dedication to improving healthcare solutions. His contributions continue to influence the landscape of medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…